Clinical trials
Completed Immunologic Deficiency Syndromes trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
98 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 5 |
| 2002 | 7 |
| 2004 | 2 |
| 2005 | 5 |
| 2006 | 4 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 4 |
| 2011 | 6 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 5 |
| 2016 | 7 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 7 |
| 2021 | 6 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 98 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 17 |
| National Cancer Institute (NCI) | 7 |
| Sumitomo Pharma Switzerland GmbH | 5 |
| University of California, San Francisco | 4 |
| Children's Hospital of Philadelphia | 3 |
| Grifols Therapeutics LLC | 3 |
| Children's Hospital of Fudan University | 2 |
| Green Cross Corporation | 2 |
| Radboud University Medical Center | 2 |
| St. Jude Children's Research Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immunologic Deficiency Syndromes | 98 |
| HIV Infections | 14 |
| Acquired Immunodeficiency Syndrome | 9 |
| Infections | 9 |
| Primary Immunodeficiency Diseases | 8 |
| Hemoglobinopathies | 7 |
| Neoplasms | 6 |
| Severe Combined Immunodeficiency | 6 |
| Anemia, Sickle Cell | 5 |
| Immune System Diseases | 5 |
Trials
Showing 76 to 98 of 98. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.